{"id":26239,"date":"2016-05-31T09:31:44","date_gmt":"2016-05-31T16:31:44","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/2016\/05\/first-gene-therapy-for-children-is-approved-in-europe-radical-treatment-for-rare-bubble-boy-disorder-has-a-100-survival-rate"},"modified":"2017-04-24T20:41:52","modified_gmt":"2017-04-25T03:41:52","slug":"first-gene-therapy-for-children-is-approved-in-europe-radical-treatment-for-rare-bubble-boy-disorder-has-a-100-survival-rate","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2016\/05\/first-gene-therapy-for-children-is-approved-in-europe-radical-treatment-for-rare-bubble-boy-disorder-has-a-100-survival-rate","title":{"rendered":"First gene therapy for children is approved in Europe: Radical treatment for rare \u2018bubble boy\u2019 disorder has a 100% survival rate"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/first-gene-therapy-for-children-is-approved-in-europe-radical-treatment-for-rare-bubble-boy-disorder-has-a-100-survival-rate.jpg\"><\/a><\/p>\n<p>Great news for precision medicine.<\/p>\n<hr>\n<p>European regulators have given the green light for a British drug firm to produce the world\u2019s first gene therapy treatment for children.<\/p>\n<p>GlaxoSmithKline was given approval by the European Commission to provide the treatment to children with a rare immune disorder \u2014 which can be fatal for those affected.<\/p>\n<p>The treatment, called Strimvelis, is the first stem cell gene therapy to treat children with severe combined immunodeficiency \u2014 commonly referred to as \u2018bubble boy\u2019 syndrome.<\/p>\n<p><!-- Link: <a href=\"http:\/\/www.dailymail.co.uk\/sciencetech\/article-3617260\/GlaxoSmithKline-provide-unique-child-gene-therapy.html\">http:\/\/www.dailymail.co.uk\/sciencetech\/article-3617260\/Glaxo...erapy.html<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Great news for precision medicine. European regulators have given the green light for a British drug firm to produce the world\u2019s first gene therapy treatment for children. GlaxoSmithKline was given approval by the European Commission to provide the treatment to children with a rare immune disorder \u2014 which can be fatal for those affected. The [\u2026]<\/p>\n","protected":false},"author":395,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-26239","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/26239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/395"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=26239"}],"version-history":[{"count":2,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/26239\/revisions"}],"predecessor-version":[{"id":50352,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/26239\/revisions\/50352"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=26239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=26239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=26239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}